X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31) 31
index medicus (30) 30
female (26) 26
male (26) 26
ticlopidine - analogs & derivatives (26) 26
aged (25) 25
clopidogrel (23) 23
middle aged (20) 20
stent thrombosis (16) 16
treatment outcome (16) 16
cardiac & cardiovascular systems (15) 15
hematology (15) 15
percutaneous coronary intervention (14) 14
platelet aggregation - drug effects (13) 13
platelet aggregation inhibitors - therapeutic use (12) 12
ticlopidine - therapeutic use (12) 12
peripheral vascular disease (11) 11
platelet function tests (11) 11
prasugrel (11) 11
risk factors (11) 11
stents (11) 11
cardiovascular (10) 10
platelet aggregation inhibitors - administration & dosage (10) 10
ticlopidine - administration & dosage (10) 10
inhibition (9) 9
platelet aggregation (9) 9
prasugrel hydrochloride (9) 9
time factors (9) 9
abridged index medicus (8) 8
blood platelets - drug effects (8) 8
thrombosis (8) 8
artery-disease (7) 7
coronary angiography (7) 7
impact (7) 7
internal medicine (7) 7
intervention (7) 7
platelet aggregation inhibitors - adverse effects (7) 7
platelets and blood cells (7) 7
reactivity (7) 7
ticlopidine - adverse effects (7) 7
acute coronary syndromes (6) 6
aggregation (6) 6
aspirin (6) 6
care and treatment (6) 6
double-blind (6) 6
drug therapy, combination (6) 6
heart attacks (6) 6
high platelet reactivity (6) 6
implantation (6) 6
metaanalysis (6) 6
multivariate analysis (6) 6
percutaneous coronary intervention - adverse effects (6) 6
stent (6) 6
ticlopidine - pharmacology (6) 6
adenosine diphosphate (5) 5
antiplatelet (5) 5
blood platelets (5) 5
cardiac patients (5) 5
coronary artery disease - drug therapy (5) 5
drug therapy (5) 5
drug-eluting stents (5) 5
germany (5) 5
of-function polymorphism (5) 5
piperazines - administration & dosage (5) 5
piperazines - adverse effects (5) 5
platelet aggregation inhibitors - pharmacology (5) 5
prospective studies (5) 5
purinergic p2y receptor antagonists - therapeutic use (5) 5
registries (5) 5
risk (5) 5
thiophenes - administration & dosage (5) 5
thiophenes - adverse effects (5) 5
adenosine-diphosphate (4) 4
aged, 80 and over (4) 4
angioplasty, balloon, coronary (4) 4
aspirin - therapeutic use (4) 4
cardiology (4) 4
coronary heart disease (4) 4
coronary thrombosis - etiology (4) 4
coronary thrombosis - prevention & control (4) 4
drug administration schedule (4) 4
hemorrhage - chemically induced (4) 4
kaplan-meier estimate (4) 4
percutaneous coronary intervention - methods (4) 4
percutaneous coronary intervention - mortality (4) 4
piperazines - therapeutic use (4) 4
platelet-aggregation (4) 4
predictive value of tests (4) 4
proportional hazards models (4) 4
studies (4) 4
therapy (4) 4
thiophenes - therapeutic use (4) 4
ticagrelor (4) 4
variability (4) 4
active metabolite (3) 3
adenosine - analogs & derivatives (3) 3
adenosine diphosphate - pharmacology (3) 3
aggregometry (3) 3
angioplasty, balloon, coronary - instrumentation (3) 3
aryl hydrocarbon hydroxylases - genetics (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 53, Issue 10, pp. 849 - 856
Objectives The aim of this prospective trial was to assess whether platelet reactivity to clopidogrel assessed with multiple electrode platelet aggregometry... 
Cardiovascular | Internal Medicine | clopidogrel | whole blood aggregometry | stent thrombosis | platelet aggregation | ADVERSE CARDIOVASCULAR EVENTS | PERCUTANEOUS CORONARY INTERVENTION | RESPONSIVENESS | CARDIAC & CARDIOVASCULAR SYSTEMS | INHIBITION | IMPLANTATION | PREDICTORS | RESISTANCE | BARE-METAL | ANTAGONISTS | AGGREGOMETRY | Prospective Studies | Platelet Function Tests - methods | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Humans | Kaplan-Meier Estimate | Male | Thrombosis - epidemiology | Coronary Artery Disease - mortality | Electric Impedance | Ticlopidine - analogs & derivatives | Drug-Eluting Stents - adverse effects | Electrodes | Coronary Artery Disease - therapy | Point-of-Care Systems | Thrombosis - etiology | Ticlopidine - adverse effects | Platelet Aggregation Inhibitors - pharmacology | Female | Platelet Function Tests - instrumentation | Aged | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Coenzymes | Vasodilators | Adenosine diphosphate | Coronary heart disease | Thrombosis | Stent (Surgery) | Blood clot | Aggregation | Disease transmission | Blood platelets | Analysis | Adenosine triphosphatase | Drug therapy | Intervention | Anticoagulants | Aspirin | Heart attacks | Medical imaging | Cardiovascular disease | Studies | Confidence intervals | Coronary vessels | Acute coronary syndromes | Stents | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2009, Volume 101, Issue 4, pp. 714 - 719
Journal Article
JAMA, ISSN 0098-7484, 11/2014, Volume 312, Issue 19, pp. 1981 - 1987
Journal Article
American Heart Journal, ISSN 0002-8703, 2011, Volume 162, Issue 3, pp. 518 - 526.e5
Background Pharmacodynamic studies reported an amplified on-clopidogrel platelet inhibition in smokers potentially caused by an increased metabolic drug... 
Cardiovascular | PERCUTANEOUS CORONARY INTERVENTION | CIGARETTE-SMOKING | CARDIAC & CARDIOVASCULAR SYSTEMS | INHIBITION | PLATELET-AGGREGATION | STENT THROMBOSIS | OF-FUNCTION POLYMORPHISM | REACTIVITY | EXTRINSIC FACTORS | ASSOCIATION | ACTIVE METABOLITE | Piperazines - administration & dosage | Smoking - adverse effects | Prasugrel Hydrochloride | Purinergic P2Y Receptor Antagonists - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Thiophenes - administration & dosage | Blood Platelets - physiology | Coronary Artery Disease - blood | Cytochrome P-450 CYP1A2 - blood | Dose-Response Relationship, Drug | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - administration & dosage | Female | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Piperazines - pharmacokinetics | Coronary Artery Disease - etiology | Smoking - blood | Risk Factors | Purinergic P2Y Receptor Antagonists - pharmacokinetics | Platelet Aggregation - physiology | Treatment Outcome | Coronary Artery Disease - drug therapy | Ticlopidine - analogs & derivatives | Cross-Over Studies | Thiophenes - pharmacokinetics | Aged | Hypertension | Enzymes | Heart attacks | Mortality | Statistical methods | Nitrates | Cigarettes | Studies | Variables | Body mass index | Blood platelets | Diabetes | Drug therapy | Acute coronary syndromes | Smoking | Logistics
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 02/2010, Volume 121, Issue 4, pp. 512 - 518
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 9, pp. 863 - 871
Abstract Background Aspirin administration, as part of a dual antiplatelet treatment regimen, is essential for patients undergoing percutaneous coronary... 
Cardiovascular | Internal Medicine | aspirin | high platelet reactivity | biomarker | stent thrombosis | Transluminal angioplasty | Aspirin | Cardiac patients | Studies | Heart attacks | Cardiology | Coronary vessels
Journal Article
European Heart Journal, ISSN 0195-668X, 05/2015, Volume 36, Issue 20, pp. 1252 - 1263
Journal Article
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 2014, Volume 35, Issue 34, pp. 2285 - 2294
Journal Article